Adherence is generally affected by a combination of capability (strength, dexterity, cognitive powers), opportunity (complexity, cost, availability) and motivation (intrinsic drivers, rewards, general mood).11 Based on this, it is possible to calculate relative differences in likely adherence with a quantitative analysis of typical disease impact, patient demographics, drug effects and device operating principles.12 By systematically analysing a drug delivery solution, it is possible to identify opportunities for improvement and determine the cost-benefit of investing in a wide range of design features
Pre-clinical evaluation of a modified cyclodextrin-based nanoparticle for intestinal delivery of liraglutide
Antimicrobial peptide alamethicin insertion into lipid bilayer: A QCM-D exploration
Your healthcare provider will consider your medical history, current medications, and specific health needs when determining the best treatment approach